WHO ICTRP trial
Effectiveness of LC16 in Mpox Prevention Trial
JPRN-jRCT1031230137 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT1031230137 |
|---|---|
| Public title | Effectiveness of LC16 in Mpox Prevention Trial |
| Scientific title | Randomized Controlled Trial to Evaluate the Prophylactic Effect of Mpox with LC16, a Dried Cell Culture Vaccine for Smallpox |
| Primary sponsor | Mugen Ujiie |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Mpox Mpox, monkeypox;D045908;Mpox, monkeypox |
| Interventions | The vaccine is administered by multiple inoculation using a bicuspid needle.;D014611;immunization, smallpox vaccine |
| Registration date | Jun 15, 2023 |
| Target size | 5000 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: